General Information
Drug ID
DR00209
Drug Name
Verteporfin
Synonyms
Visudyne (TN)
Drug Type
Small molecular drug
Indication Age-related macular degeneration [ICD11: 9B75.0] Approved [1]
Structure
3D MOL 2D MOL
Formula
C41H42N4O8
Canonical SMILES
CC1=C(C2=CC3=NC(=CC4=C(C(=C(N4)C=C5C6(C(C(=CC=C6C(=N5)C=C1N2)C(=O)OC)C(=O)OC)C)C)CCC(=O)OC)C(=C3C)CCC(=O)O)C=C
InChI
InChI=1S/C41H42N4O8/c1-9-23-20(2)29-17-34-27-13-10-26(39(49)52-7)38(40(50)53-8)41(27,5)35(45-34)19-30-22(4)25(12-15-37(48)51-6)33(44-30)18-32-24(11-14-36(46)47)21(3)28(43-32)16-31(23)42-29/h9-10,13,16-19,38,42,44H,1,11-12,14-15H2,2-8H3,(H,46,47)/t38-,41+/m0/s1
InChIKey
YTZALCGQUPRCGW-ZSFNYQMMSA-N
CAS Number
CAS 129497-78-5
Pharmaceutical Properties Molecular Weight 718.8 Topological Polar Surface Area 174
Heavy Atom Count 53 Rotatable Bond Count 12
Hydrogen Bond Donor Count 3 Hydrogen Bond Acceptor Count 10
XLogP
4.9
PubChem CID
5362420
PubChem SID
104222390 , 104253378 , 124757496 , 125164300 , 126682291 , 135016992 , 135692277 , 137005637 , 137240344 , 139249759 , 143338983 , 14840039 , 152159626 , 160963806 , 174006241 , 175269887 , 179149780 , 198953297 , 226397753 , 239240257 , 249896056 , 252158761 , 252451139 , 33089058 , 33089402 , 39384497 , 46506236 , 50064319 , 50071237 , 53788496 , 57362100 , 78440468
ChEBI ID
CHEBI:60775
TTD Drug ID
D0I3XG
DT(s) Transporting This Drug ABCB6 Transporter Info ATP-binding cassette sub-family B member 6 Substrate [2]
BCRP Transporter Info Breast cancer resistance protein Substrate [3]
References
1 Verteporfin was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Efficient purification and reconstitution of ATP binding cassette transporter B6 (ABCB6) for functional and structural studies. J Biol Chem. 2013 Aug 2;288(31):22658-69.
3 The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2. Clin Cancer Res. 2007 Apr 15;13(8):2463-70.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.